- Previous Close
1,301.35 - Open
1,320.10 - Bid --
- Ask --
- Day's Range
1,204.55 - 1,320.10 - 52 Week Range
1,000.60 - 1,753.95 - Volume
17,210 - Avg. Volume
7,263 - Market Cap (intraday)
7.054B - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
10.24 - EPS (TTM)
120.07 - Earnings Date Feb 10, 2025 - Feb 14, 2025
- Forward Dividend & Yield 11.50 (0.87%)
- Ex-Dividend Date Aug 2, 2024
- 1y Target Est
--
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
www.albertdavidindia.com1,497
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ALBERTDAVD.NS
View MorePerformance Overview: ALBERTDAVD.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALBERTDAVD.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALBERTDAVD.NS
View MoreValuation Measures
Market Cap
7.00B
Enterprise Value
3.81B
Trailing P/E
10.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.92
Price/Book (mrq)
1.69
Enterprise Value/Revenue
1.05
Enterprise Value/EBITDA
3.97
Financial Highlights
Profitability and Income Statement
Profit Margin
19.67%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.6B
Net Income Avi to Common (ttm)
707.73M
Diluted EPS (ttm)
120.07
Balance Sheet and Cash Flow
Total Cash (mrq)
2.85B
Total Debt/Equity (mrq)
0.87%
Levered Free Cash Flow (ttm)
--